Drawing for VIASKIN

USPTO serial 79041967

VIASKIN

Reviewed by CopyMark Law Group

Status 402
Filing date
Status date
Registration date
Examiner
TURNER, JASON FITZGERALD
Law office
TMEG LAW OFFICE 108 - EXAMINING ATTORNEY ASSIGNED

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with VIASKIN?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Transdermal patches for use in the treatment of allergy, vaccination, transcutaneous drug delivery and cosmetics through cutaneous or epicutaneous administration means of powdered medical or pharmaceutical substances for human or animal purposes, Transdermal patches containing a preparation in powder form for medical use in the treatment of allergy, vaccination, transcutaneous drug delivery and cosmetics; transdermal occlusive patch for cutaneous absorption of a powdered medicated substance for use in the treatment of allergy, vaccination, transcutaneous drug delivery and cosmetics; Transdermal patches for vaccine administration; Transdermal patches for cosmaceutical epidermal therapies; Transdermal patches for use in the treatment, prevention, or diagnosis of allergies, Transdermal patches for use in dermatology; Transdermal patches for use in oncology; Transdermal patches containing medicineSECTION 70 - CANCELLED
010Transdermal drug delivery patches sold without medication; Medical apparatus and instruments for cutaneous or epicutaneous administration of powdered medicated or cosmetic substances for use in diagnosing allergies; Medical apparatus and instruments for cutaneous or epicutaneous administration of powdered medicated or cosmetic substances for use in vaccine administration; Medical apparatus and instruments for cutaneous or epicutaneous administration of powdered medicated or cosmetic substances for use in cosmaceutical epidermal therapies; Medical apparatus and instruments for use in cutaneous or epicutaneous administration of powdered medicated or cosmetic substances for use in dermatology and oncology treatments; Medical apparatus and instruments for cutaneous or epicutaneous administration of powdered medicated or cosmetic substances for medical useSECTION 70 - CANCELLED

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Dec 16, 2017DENANOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Dec 15, 2017DETHDEATH OF INTERNATIONAL REGISTRATION
Feb 17, 2017ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB
Nov 12, 2013ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB
Dec 18, 2009FINTFINAL DECISION TRANSACTION PROCESSED BY IB
Nov 18, 2009FICSFINAL DISPOSITION NOTICE SENT TO IB
Nov 18, 2009FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Mar 5, 2009OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Feb 19, 2009OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Feb 19, 2009OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Nov 18, 2008MAB2ABANDONMENT NOTICE MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Nov 18, 2008ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Apr 16, 2008GNFNNOTIFICATION OF FINAL REFUSAL EMAILED
Apr 16, 2008GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Apr 16, 2008CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Mar 24, 2008TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 24, 2008TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Mar 24, 2008CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 24, 2008TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 13, 2007RFNTREFUSAL PROCESSED BY IB
Sep 24, 2007RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sep 24, 2007RFRRREFUSAL PROCESSED BY MPU
Sep 22, 2007RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 21, 2007CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 14, 2007DOCKASSIGNED TO EXAMINER
Sep 14, 2007NWAPNEW APPLICATION ENTERED
Sep 13, 2007REPRSN ASSIGNED FOR SECT 66A APPL FROM IB

Frequently asked questions

Related guidance